NEWS1 wire brief. This page keeps the update readable on-site while clearly pointing to the original publisher for the full report.
The agency’s former top vaccine regulator declined to review the Moderna shot, and it’s now likely to face pushback from allies of the health secretary.
The Food and Drug Administration has approved the first mRNA-based flu vaccine, paving the way for a new type of shot that will be available for adults 50 and over looking to get immunized against th…
What we know
- Source: The Washington Post
- Byline: Rachel Roubein
- Published: 06 Aug 2026 05:26
This briefing is based on source metadata delivered through NewsAPI. Open the original publisher below for the full article and continuing updates.